Surfing the MASH Tsunami
Podcast image
S4-E34.1 - The Excitement of FASN Inhibitors: Positive 2B Interim Data for Denifanstat
11 mins; July 29, 2023
S4-E34 - Drug Development Stories from EASL and ADA: Part 2
64 hours 9 mins; July 26, 2023
S4-E33.5 - From the Vault: ILC 2022 Looking Back: NASH Is a Complex Disease
13 mins; July 23, 2023
S4-E33.4 - More Presentation Insights on Frequency of Testing, NITs and Biopsy
16 mins; July 23, 2023
S4-E33.3 - Steatotic Liver Disease, HCC and Mechanisms of Fibrosis Resolution
12 mins; July 22, 2023
S4-E33.2 - Unmet Needs in the Primary Care Setting for Disease Identification
12 mins; July 22, 2023
S4-E33.1 - EASL Congress 2023: Focus on New Nomenclature
15 mins; July 22, 2023
S4-E33 - EASL Congress: Nomenclature and More Compelling Presentations
55 mins; July 19, 2023
S4-E32.5 - From the Vault: ILC 2022 Looking Back: Crystal Balling & The Semaglutide Trial
12 mins; July 16, 2023
S4-E32.4 - The Potential of NASH Drugs as Adjuvant Therapy
10 mins; July 16, 2023
S4-E32.3 - Discussing Other Drugs in the Therapeutic Landscape
13 mins; July 15, 2023
S4-E32.2 - Why We Should Develop Deeper Understanding of Liver Volume
11 mins; July 15, 2023
S4-E32.1 - Lead Principle Investigator Stephen Harrison Recaps the MAESTRO-NASH Program for Resmetirom
14 mins; July 15, 2023
S4-E32 - Drug Development Stories from EASL and ADA: Part 1
48 mins; July 12, 2023
S4-E31.4 - EASL Congress and ADA Scientific Sessions: Reshaping the way we think about Fatty Liver Disease
16 mins; July 09, 2023
S4-E31.3 - Jörn Schattenberg on the Therapeutic Landscape and Fibrosis Resolution
13 mins; July 09, 2023
S4-E31.2 - What do we know about mechanisms of action in NASH drugs and the commercial implications?
13 mins; July 09, 2023
S4-E31.1 - Mazen Noureddin on "NASH Monopoly"
15 mins; July 09, 2023
S4-E31 - Mazen Noureddin and Jörn Schattenberg on the Developing Therapeutic Landscape
56 mins; July 07, 2023
S4-E30.4 - EASL Congress 2023: Final Takeaways
14 mins; July 02, 2023
S4-E30.3 - EASL Congress 2023: More Posters and Presentations
20 mins; July 02, 2023
S4-E30.2 - EASL Congress 2023: Scoring Systems to Evaluate NASH
11 mins; July 02, 2023
S4-E30.1 - EASL Congress 2023: Nomenclature Rollout
17 mins; July 02, 2023
S4-E29.3 - EASL Congress 2023: Final Thoughts on Days 1-3
17 mins; July 01, 2023
S4-E29.2 - EASL Congress 2023: Challenges in Patient Screening and the “2nd Wave” of NASH Therapeutics
14 mins; July 01, 2023
S4-E29.1 - EASL Congress 2023: Presentation on MAESTRO-NASH Phase 3 Results
13 mins; July 01, 2023
S4-E30 - EASL Congress 2023: Real-Time Review Part 2
56 mins; June 26, 2023
S4-E29 - EASL Congress 2023: Real-Time Review Part 1
42 mins; June 25, 2023
S4-E28 - Tetiana Deshko on the public health care in Ukraine during the invasion
30 mins; June 22, 2023
S4-E27.6 - Deep Dive into AI and Pathology with Arun Sanyal and David Kleiner
34 mins; June 18, 2023
S4-E27.5 - EASL Congress 2023: Exploring Technology for Identifying Patients
11 mins; June 18, 2023
S4-E27.4 - Previewing EASL Congress 2023 with Louise Campbell: Frontline Screening
15 mins; June 18, 2023
S4-E27.3 - Abstract session - NAFLD: Clinical Aspects
10 mins; June 17, 2023
S4-E27.2 - Abstract session - NAFLD: Therapy
12 mins; June 17, 2023
S4-E27.1 - Unpacking the Program with Ian Rowe and Jörn Schattenberg
13 mins; June 17, 2023
S4-E27 - EASL Congress 2023 Preview: Great Talks to Anticipate!
89 hours 38 mins; June 14, 2023
S4-E25.5 - Wrap-Up on NICE Guidance for FibroScan
9 mins; June 12, 2023
S4-E25.4 - NICE Guidance for FibroScan: The Devil is in the Details
11 mins; June 12, 2023
S4-E25.3 - The Future of FibroScan and Optimizing Availability of Quality Scanning
9 mins; June 12, 2023
S4-E25.1 - Meeting Vanessa Hebditch and the Role of the British Liver Trust in Fighting for FibroScan
13 mins; June 11, 2023
S4-E25.2 - NICE Guidance for FibroScan: Collecting Data Well and Wisely
14 mins; June 11, 2023
S4-E26.4 - International #NASHDay 2023 Wrap-Up
12 mins; June 11, 2023
S4-E26.3 - FibroScan and the Impact of Socioeconomic Factors on Liver Health
16 mins; June 10, 2023
S4-E26.2 - Discussing the Rise of NAFLD/NASH in Adolescents
12 mins; June 10, 2023
S4-E26.1 - What Patient Advocate Organizations Are Doing Around the World in Support of #NASHDay 2023
16 mins; June 10, 2023
S4-E26 - Patient Advocate Focus on International #NASHDay 2023
59 mins; June 09, 2023
S4-E25 - Exciting News! NICE Guidance Supports FibroScan Use Outside Secondary and Specialist Care in the UK
55 mins; June 08, 2023
S4-E24.6 - From the Vault: Did the Innovations in NAFLD Care Conference Strengthen the Case for an Integrated NAFLD Care Pathway?
11 mins; June 04, 2023
S4-E24.5 - INCBCN Review: Wrap-Up Comments and Moving Forward
15 mins; June 04, 2023
S4-E24.4 - INCBCN Day 2 Summary
9 mins; June 04, 2023
S3-E24.3 - Focus on Preventative Hepatology
12 mins; June 03, 2023
S4-E24.2 - INCBCN Review: NAFLD and Social Drinking
11 mins; June 03, 2023
S4-E24.1 - INCBCN Review: NASH-NITs Real-World-Evidence Summit
11 mins; June 03, 2023
S4-E24 - Reviewing the 2023 Innovations in NAFLD Care Workshop
57 mins; May 31, 2023
S4-E21.5 - From the Vault: ILC 2022 Looking Back: NASH Is a Complex Disease
14 mins; May 28, 2023
S4-E21.4 - Virtual EASL Congress 2023 and the Power of Posters
16 mins; May 28, 2023
S4-E21.3 - Curating the EASL 2023 Program and 3 “Can’t Miss” Features
16 mins; May 28, 2023
S4-E21.2 - Previewing EASL Congress 2023: Highlighting Exciting Elements
11 mins; May 28, 2023
S4-E21.1 Meeting Aleksander Krag and Setting the Stage for EASL Congress 2023
13 mins; May 28, 2023
S4-E23.4 - Deep Dive into Hepatocellular Ballooning and the Power of AI
9 mins; May 27, 2023
S4-E23.3 - Lowering Screen Fail Rates and Guidelines for the Biopsy Reading Process
9 mins; May 27, 2023
S4-E23.1 - Obeticholic Acid: Is the Juice Worth the Squeeze?
14 mins; May 27, 2023
S4-E23.2 - The Future of AI-Assisted Digital Pathology and NITs
14 mins; May 27, 2023
S4-E23 - Stephen Harrison on Challenges and Opportunities in NASH Drug Development
42 mins; May 24, 2023
S4-E22 - PART 1: FDA ADCOM Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis Due to NASH
32 mins; May 22, 2023
S4-E21 - Surfing NASH Previews EASL Congress 2023
51 mins; May 17, 2023
S4-E20.6 - From the Vault: Discussing NITs and Final Thoughts on NAFLD Summit
14 mins; May 14, 2023
S4-E20.5 - Harnessing the Strengths of the Patient Advocate Community
11 mins; May 14, 2023
S4-E20.4 - Donna Cryer’s Call to Action for Patient Advocacy in the NASH Community
8 mins; May 14, 2023
S4-E20.3 - Generating and Promoting the Data to Demonstrate Patient Needs
12 mins; May 13, 2023
S4-E20.2 - Listening to Both Sides: Allied Health for Patient Empowerment
12 mins; May 13, 2023
S4-E20.1 - Who is going to be the Larry Kramer of NASH?
12 mins; May 13, 2023
S4-E20 - Leveraging Patient Voice and Needs in the NASH Community
55 mins; May 11, 2023
S4-E19.6 - From the Vault: REGENERATE Redux: Clearing The Finish Line?
13 mins; May 07, 2023
S4-E19.5 - Teasing the Difference Between Patient Advocate Voice and Patient Advocate Vote
10 mins; May 07, 2023
S4-E19.4 - Patient Advocates Describe the Reasoning Behind Their Testimonies
11 mins; May 07, 2023
S4-E19.3 - The Role of Biopsy in Prescribing NASH Therapeutics
10 mins; May 06, 2023
S4-E19.2 - Patient Advocates React to the Word “Empathy”
11 mins; May 06, 2023
S4-E19.1 - How Did the Patient Advocates Come to Offer Testimonies?
8 mins; May 06, 2023
S4-E19 - Patient Advocate Panel Responds to ICER Draft Report on Resmetirom and Obeticholic Acid for NASH
46 mins; May 04, 2023
S4-E18.6 - From the Vault: Clinical Care Pathway: What Can Be Done Today?
18 mins; April 30, 2023
S4-E18.5 - Allied Health Professionals and Patient Identification in Endocrinology Clinics
13 mins; April 30, 2023
S4-E18.4 - Empowering Physicians Through Simple Tools and the Demise of Beethoven
10 mins; April 30, 2023
S4-E18.3 - Positive Patient Engagement with Biofeedback and NAFLD/NASH in Chronic Kidney Patients
10 mins; April 29, 2023
S4-E18.2 - Risk Stratification and Identification of NAFLD/NASH Patients in the Endocrinology Setting
14 mins; April 29, 2023
S4-E18.1 - Meeting Cyrielle Caussy at the Intersection of Endocrinology and Hepatology
12 mins; April 29, 2023
S4-E18 - Interplay of Endocrinology and Hepatology in Treatment and Knowledge Development
54 mins; April 26, 2023
S4-E17.8 - Predictions for the Surfing NASH 6th Anniversary Special
17 mins; April 23, 2023
S4-E17.7 - Discussing the Drug Development Landscape and Growing Community Education
15 mins; April 23, 2023
S4-E17.6 - The Trajectory of Liver Science: How Far Have We Come?
15 mins; April 22, 2023
S4-E17.5 - Surfer Throwbacks: Meeting the Co-Hosts for the First Time
12 mins; April 22, 2023
S4-E17.4 - Stephen Harrison on Improving Clinical Trial Enrollment and Reminiscing on the Podcast’s Early Days
14 mins; April 22, 2023
S4-E17.3 - Surfing NASH 3rd Anniversary Special: Interview with Frédéric Cren of Inventiva Pharma
16 mins; April 21, 2023
S4-E17.2 - Surfing NASH 3rd Anniversary Special: Interview with Donna Cryer of the Global Liver Institute
19 mins; April 21, 2023
S4-E17.1 - Surfing NASH 3rd Anniversary Special: Interview with Amy Articolo of Novo Nordisk
17 mins; April 21, 2023
S4-E17 - Surfing the NASH Tsunami 3rd Anniversary Special
103 hours 36 mins; April 19, 2023
S4-E16.6 - From the Vault: #NASHDay 2022: SurfingNASH Wrap-Up
16 mins; April 16, 2023
S4-E16.5 - How Do We Step Up to NASH?
9 mins; April 16, 2023
S4-E16.4 - #NASHDay and Activating Awareness Across Communities
12 mins; April 16, 2023
S4-E16.3 - The Untapped Potential of the Liver Community
10 mins; April 15, 2023